LICR Company Profile

07:14 EDT 24th June 2018 | BioPortfolio

LICR is distinguishable from other cancer research institutes, not only by its size and global reach, but also by two fundamental attributes: its reliable, long-term funding perspective and the fact that it takes responsibility for the entire discovery continuum from the laboratory to the clinic.
A limitation of the traditional academic cancer research model is that funding is fragmented, overlapping and lacks strategic coordination. Universities and research institutes usually are not themselves able to finance a significant portion of the research conducted on their campuses. Rather, grants made directly to the individual investigators for individual projects are the principal source of funding for academic research. Consequently, the capacity of universities and institutes to influence the content or character of the work carried out by their faculty, or to bring together individuals or laboratories to create a larger, more synergistic research endeavor is diminished. The result is a system in which the research undertaken is predominantly defined by what can be achieved in a single laboratory within a funding cycle of, typically, three years. Though this research funding model has been effective, it supports a rather narrow range of disjointed activity. It does not encourage collaborative and coordinated undertakings or enable longer term, broad scale initiatives. In contrast, LICR funds over 70% of the cost of the research that it conducts. Though its most basic science is investigator-initiated, LICR encourages, enables and brings together multidisciplinary teams of investigators to tackle larger, more complex cancer challenges.


605 Third Avenue
New York
New York
United States of America


Phone: (1) 212 450 1500
Fax: (1) 212 450 1555

News Articles [2 Associated News Articles listed on BioPortfolio]

iTeos Therapeutics: Combating cancer using immunotherapy against novel target combinations

iTeos Therapeutics is a spin-off from the Ludwig Cancer Research (LICR) and de Duve Institute (UCL). Focused on expanding the benefits of immunotherapy for cancer patients, the company is developing a...

Ludwig Institute For Cancer Research Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13032018] Prices from USD $250

SummaryLudwig Institute for Cancer Research Ltd LICR is a nonprofit organization that conducts cancer research and clinical trial programs. The organization offers patents, licensing, contracts, portf...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [2 Associated Companies listed on BioPortfolio]


LICR is distinguishable from other cancer research institutes, not only by its size and global reach, but also by two fundamental attributes: its reliable, long-term funding perspective and the fact t...

Serametrix Corporation

Serametrix provides solutions to the problem of monitoring immune response to immunotherapies in clinical trial cancer patients. In partnership with leading institutes Sera...

More Information about "LICR" on BioPortfolio

We have published hundreds of LICR news stories on BioPortfolio along with dozens of LICR Clinical Trials and PubMed Articles about LICR for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of LICR Companies in our database. You can also find out about relevant LICR Drugs and Medications on this site too.

Quick Search


Relevant Topics

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record